0001213900-21-036355.txt : 20210709 0001213900-21-036355.hdr.sgml : 20210709 20210709160656 ACCESSION NUMBER: 0001213900-21-036355 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210707 FILED AS OF DATE: 20210709 DATE AS OF CHANGE: 20210709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lowdell Mark William CENTRAL INDEX KEY: 0001767037 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 211082917 MAIL ADDRESS: STREET 1: THE OAK, WLX ROAD CITY: BEAUMONT STATE: X0 ZIP: CO16 0AT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2021-07-07 0 0001711754 Inmune Bio, Inc. INMB 0001767037 Lowdell Mark William C/O INMUNE BIO INC. 980 NORTH FEDERAL HIGHWAY, SUITE 110 BOCA RATON, FL 33432 0 1 0 0 Chief Scientific Officer Common Stock 2021-07-07 2021-07-07 4 S 0 5850 20.02 D 1500401 D Common Stock 2021-07-08 2021-07-08 4 S 0 24150 20.19 D 1476251 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.04, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.48, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above. /s/ Mark William Lowdell 2021-07-09